Infusion device
11040136 · 2021-06-22
Assignee
Inventors
- Andrew Sluggett (South Australia, AU)
- Danny Djurasevich (South Australia, AU)
- Paul Crockett (South Australia, AU)
- Gabriel Ash (South Australia, AU)
Cpc classification
A61M5/14212
HUMAN NECESSITIES
A61M5/16831
HUMAN NECESSITIES
A61M2005/14208
HUMAN NECESSITIES
A61M5/14228
HUMAN NECESSITIES
A61M2005/14506
HUMAN NECESSITIES
A61M5/14244
HUMAN NECESSITIES
A61M2005/14264
HUMAN NECESSITIES
G06F12/14
PHYSICS
A61M2207/00
HUMAN NECESSITIES
A61M2205/0216
HUMAN NECESSITIES
A61M2205/52
HUMAN NECESSITIES
International classification
G06F12/14
PHYSICS
A61M5/14
HUMAN NECESSITIES
A61M5/168
HUMAN NECESSITIES
Abstract
Some embodiments are directed to portable devices for transferring fluids from an external source and controllably infusing the fluids into a patient, particularly portable infusion pump devices, and protective housings for such devices, which include a pump unit, a computer, a portable fuel source, and a seal for securing the contents substantially within the protective housings of the device. Some embodiments may be formed as a single infusion pump unit or may be formed when two infusion pump units are engaged. Some embodiments also relate to methods of use of portable devices and method for the manufacture of portable devices and protective housings for such devices.
Claims
1. A non-implantable portable device for transferring fluids from an external vessel via an administration set and controllably infusing the fluids into a patient, the portable device comprising: a protective housing including a first protective housing piece that includes a first wall defining an infusion line aperture that extends through the first wall, the protective housing defining an internal cavity that is contiguous with the infusion line aperture; infusion tubing configured to allow the fluids to pass therethrough, the infusion tubing including a first portion and a second portion, the first portion and the second portion extending through the first wall, the first portion being disposed within the infusion line aperture, the first portion including an infusion line in configured to engage the external vessel for transporting fluids from the external vessel, the second portion including an infusion line out configured to engage with a patient's vascular access device for transporting fluids to the patient; a seal disposed at the protective housing and configured to substantially isolate the internal cavity from an exterior of the protective housing; a pump disposed within the internal cavity; a power source disposed within the internal cavity that provides power to the pump; an on-board computer for controlling the pump to draw the fluids through the infusion line in and/or the infusion line out at a preset flow rate, the on-board computer being disposed within the internal cavity of the protective housing; and a computer programming interface configured for receiving instructions for the preset flow rate at which the on-board computer controls the pump, the computer programming interface being entirely disposed within the internal cavity as to be inaccessible from the exterior of the protective housing to thereby impede manually re-programming the preset flow rate.
2. The non-implantable portable device of claim 1, further including an occlusion sensor and a pump actuator that are substantially disposed within the internal cavity.
3. The non-implantable portable device of claim 2, wherein the on-board computer includes a processor, and the computer programming interface is configured to receive instructions from a user for modulating the activity of the pump actuator.
4. The non-implantable portable device of claim 1, wherein the computer programming interface comprises a memory device reader.
5. The non-implantable portable device of claim 1, wherein the computer programming interface comprises a removable memory device reader, is configured to impede editing subsequent to installation within the internal cavity, and is configured to receive a pre-programmed memory device.
6. The non-implantable portable device of claim 1, wherein the computer programming interface comprises a wireless signal receiver, and is configured to impede editing subsequent to installation within the internal cavity.
7. The non-implantable portable device of claim 1, wherein the protective housing includes a second protective housing piece that includes a second wall and the seal formed between the first wall and the second wall, and configured to substantially isolate the internal cavity from an exterior of the protective housing so as to impede access to the pump from the exterior of the protective housing, the computer programming interface being disposed within the sealed internal cavity so as to be inaccessible from the exterior of the protective housing to thereby impede manually re-programming the preset flow rate.
8. The non-implantable portable device of claim 7, wherein the non-implantable portable device is configured to be wearable by a user and the first protective housing piece and second protective housing piece are formed from a substantially impervious, firm material capable of providing shock absorption.
9. The non-implantable portable device of claim 1, wherein the computer programming interface and the on-board computer comprises a memory device reader, is configured to impede editing subsequent to installation within the internal cavity, and is configured to receive a pre-programmed memory device.
10. The non-implantable portable device of claim 9, wherein the first wall or a second wall of the protective housing is configured to receive the memory device reader therethrough.
11. The non-implantable portable device of claim 1, wherein the pump further includes an occlusion sensor and a pump actuator, and the computer programming interface is configured to receive instructions from a user for modulating the activity of the pump actuator.
12. The non-implantable portable device of claim 11, wherein the on-board computer is a memory device reader, the on-board computer being operated by software configured to impede editing subsequent to installation of the on-board computer within the protective housing, the on-board computer being configured to receive a pre-programmed memory device, and the protective housing being configured to receive the pre-programmed memory device there through.
13. A method of manufacturing the non-implantable portable device according to claim 7, comprising: placing the pump within the internal cavity defined by the protective housing; and deploying the seal to engage the second protective housing piece with the first protective housing piece to secure the pump within the internal cavity of the protective housing.
14. A method of manufacturing the non-implantable portable device according to claim 1, comprising: placing the pump and the on-board computer within the internal cavity of the protective housing; placing a part of the infusion tubing within the infusion line aperture; and deploying the seal to secure the pump and the on-board computer within the internal cavity of the protective housing.
15. A method of controllably infusing fluids into a patient, comprising: obtaining the non-implantable portable device according to claim 1, obtaining the fluids contained within the external vessel; connecting a vascular access device to the patient; connecting a vascular access device fitting to a terminal end of the infusion line out; connecting the infusion line in to the external vessel; connecting the infusion line out to the patient; priming the infusion tubing; and activating the non-implantable portable device.
16. A non-implantable portable device for transferring fluids from an external vessel via an administration set and controllably infusing the fluids into a patient, the portable device comprising: a protective housing including a first protective housing piece that includes a first wall defining infusion line apertures that extend through the first wall, the protective housing defining an internal cavity that is contiguous with the infusion line apertures; infusion tubing configured to allow the fluids to pass therethrough, the infusion tubing including a first portion and a second portion, the infusion line apertures being configured to allow the first portion and the second portion to extend through the first wall, the first portion including an infusion line in configured to engage the external vessel for transporting fluids from the external vessel, the second portion including an infusion line out configured to engage with a patient's vascular access device for transporting fluids to the patient; a seal disposed at the protective housing and configured to substantially isolate the internal cavity from an exterior of the protective housing; a pump disposed within the internal cavity; a power source disposed within the internal cavity that provides power to the pump; an on-board computer for controlling the pump to draw the fluids through the infusion line in and/or the infusion line out at a preset flow rate, the on-board computer being disposed within the internal cavity of the protective housing; and a computer programming interface configured for receiving instructions for the preset flow rate at which the on-board computer controls the pump, the computer programming interface being entirely disposed within the internal cavity as to be inaccessible from the exterior of the protective housing to thereby impede manually re-programming the preset flow rate.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
Examples
(11) Several embodiments are described in the following examples.
Example 1—Infusion Pump Design
(12)
(13)
(14) The infusion lines in and out (130 and 132) terminate in a leur lock coupling. The infusion line in (130) is coupled with a patient's administration set including an in-line occlusion filter and a peripherally inserted central catheter line (PICC line) for vascular access.
(15)
(16)
(17)
(18)
(19) An alternative inner chassis may be formed from silicon potting compound (not shown). A potted chassis is formed following placement of the assembled mechanical and electrical componentry within the lower exterior housing. The silicon potting compound is formed and prepared for use according to the manufacturer's instructions and poured within the lower exterior housing to fill the lower exterior housing. The compound is then allowed to cure under conditions recommended by the manufacturer. The upper and lower exterior housing are then assembled in the usual manner described herein.
(20) In this alternative form, the hardened potting compound performs in a similar manner to the fabricated chassis including cut away portions; fixing the placement of the mechanical and electrical componentry within the outer housing and providing cushioning and shock resistance to the infusion pump.
(21) In a further alternative form, a silicon potting material may be used in place of the dual silicon seals and the inner chassis to prevent the ingress of moisture and small particulate material such as sand and dust, which may damage the pump componentry. The lower exterior housing may be formed to completely contain the pump componentry and the infusion lines passing through the housing therein. Once the mechanical and electrical componentry of the pump has been placed and assembled within the lower exterior housing, the infusion line is then placed within the pump. The lower exterior housing is filled with silicon potting compound until all of the components of the pump, and the infusion lines, are submerged in the silicon potting material. The potting material is again allowed to cure, at which time the upper exterior housing may be secured to the lower exterior housing by any one of many methods well known to persons of ordinary skill in the art (for example by using an appropriate silicon bonding agent). The upper exterior housing is effectively cosmetic, as the potting material forms an effective seal preventing the ingress of moisture or particulates to the pump componentry, and furthermore secures the placement of components within the lower exterior housing providing resistance to damage caused by shock or movement.
(22)
(23)
(24) In an alternative embodiment, the lower exterior housing may provide a larger cavity, wherein all infusion pump componentry may be placed therein. In such embodiments, the internal cavity of the lower exterior housing containing the infusion pump componentry and infusion lines to and from the pump may be filled with silicon potting compound (in accordance with the manufacturer's instructions). The hardened potting compound seals and renders water resistant the internal componentry of the infusion pump without the need for additional sealing or assembly of an upper exterior housing. In addition, the hardened potting compound maintains the administration lines in and out of the infusion pump in a fixed, sealed position. The complete unit may be readily sterilized and disposed after use.
Example 2—Disposable Cassette Design
(25) Infusion pumps of some embodiments may be formed in two pieces whereby the two pieces are brought together to provide a complete functional infusion pump device.
(26)
(27) Lower exterior housing (112) is shown as being of identical shape and conformation to the earlier lower exterior housing piece, for realizing economies of scale in small batch manufacture of single piece pumps and two-piece pumps. The lower exterior housing illustrated in
(28)
(29) The pump insert fits securely within opening (270). Groove runners (230) and grooves (240) provide a tongue and groove mechanism to guide the correct placement the pump insert within the cassette piece. Correct placement of the pump insert ensures that the peristaltic pump cams (not shown) compress the infusion lines to push fluids through the line. Correct placement may also be necessary to ensure that the power connectors (280) at the pump insert and the cassette piece make contact. Once in position, the pump insert is locked in place by a terminal clip in the groove runners (230) and by locking clips (220). The single silicon seal (210) around the perimeter of pump insert housing (290) maintains an impermeable seal between the cassette piece and the pump insert.
(30)
(31)
(32)
(33) While both the cassette piece and pump insert are sterilisable, the pump is provided in two portions to provide the option of re-sterilizing or simply reusing the pump insert, while the cassette piece may be replaced together with the patent's administration set.
(34) As described above in relation to Example 1, it is anticipated that the inner chassis provided in the two-piece infusion pump may be readily substituted for a suitable silicon potting material in accordance with the methods provided above.
Example 3—Infusion Pump Use
(35) Operative Tolerances
(36) During operation, the infusion pump flow rate will be pre-programmed at a set specific flow rate. For the majority of indications, the set flow rate will be between 1.5 ml/hour and 10 ml/hour. The infusion pump also includes a “keep line open” function. When the infusion program is complete, the pump continues with a flow rate of the lower programmed flow rate or 0.5 ml/hr for 4 hours.
(37) The infusion pump will continue to infuse at the set rate until the infusion fluid is depleted. The pump will detect that there is no fluid available to infuse and initiate a termination sequence. Alternatively, the pump will sense that the lower threshold fluid volume level is no longer met and/or that the calculated infusion period has elapsed and will initiate a termination sequence.
(38) The infusion pump infuses continuously at the set rate provided that an average flow rate at the pre-set rate over a five-minute period is achieved. In addition, the flow rate must or should fall within a tolerance level of at least +/−6% of the set flow rate. However, for some indications the tolerance level may be set as low as +/−2% of the set flow rate.
(39) The flow rate must or should fall within the desired tolerance level at atmospheric pressures ranging from 695 to 1000 hPa, at ambient temperatures ranging from −10° C. to +40° C., at atmospheric relative humidity ranges of between 10% to 90% non-condensing, and for medication temperatures from +2° C. to +22° C. The infusion pump is also suitable for storage at temperatures of up to +70° C.
(40) The infusion pump adapts to the administration of fluid of a wide range of viscosities. An adjusted flow rate may either be calculated on pre-set values of fluid viscosity, or a sensed viscosity may trigger a flow rate adjustment in real time. Flow rate adjustments are made for viscosities ranging from 0.7 mm.sup.2/s-1.7 mm.sup.2/s.
(41) The maximum pumping pressure must or should be set at 1200 mmHg. A backflow prevention device is also included in the system, effective to a pressure of up to 1200 mmHg. At maximum pressure and flow rate the pump will only emit a noise level less than 40 dB (A) at 0.5 m.
(42) Malfunction Protection
(43) When a maximum threshold flow rate is breached a malfunction sequence is initiated, involving the termination of the pump and/or motor mechanism and signaling of the alarm mechanism, to ensure the patient is not subjected to an overdose. This safety feature offers protection in the event of a pump malfunction.
(44) An occlusion malfunction sequence is initiated in response to an upstream or downstream occlusion event. When line pressure is detected as reaching the threshold of 825 mmHg (160 kPa)+/−375 mmHg16 (50 kPa), the pump commences pause mode and stops pumping. The event also initiates an alarm (not audible). The pump will resume the pre-set infusion regimen once the occlusion is removed.
(45) Administration sets suitable for use with the infusion pump include an in-line filter and venting system to remove the passage of particulates or air passing to the patient.
(46) Suitable administration sets must or should also include an infusion line clamp for the manual cessation of infusion as an additional safety feature in the event of a pump or motor malfunction.
(47) Physical Features
(48) The infusion pump includes an activation mechanism and an indication light located beneath the outer housing, which indicates the operational status of the infusion pump. A green static light indicates the operational status of the infusion pump and changes color to red during a malfunction or termination sequence. The infusion pump does not include an externally programmable programming interface. The infusion sequence is pre-programmed on an internal microSD card which cannot be amended once the pump has been assembled and sterilized.
(49) The infusion tubing terminates in a luer-lock connection for connection with a variety of infusion bags and vascular access devices (VADs) (midline, central, intrathecal etc.).
(50) The infusion pump allows for extended infusions without need to change batteries; between 24 hours at 10 ml/hour and 48 hours at 10 ml/hour.
(51) Throughout this specification the word “include”, or variations such as “includes” or “including”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
(52) All publications mentioned in this specification are herein incorporated by reference. Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for some embodiments. It is not to be taken as an admission that any or all of these matters form part of the related art base or were common general knowledge in the field relevant to some embodiments as it existed in Australia or elsewhere before the priority date of each claim of this application.
(53) While the presently disclosed subject matter has been described above in terms of specific embodiments, it is to be understood that the presently disclosed subject matter is not limited to these disclosed embodiments. Upon reading the teachings of this disclosure many modifications and other embodiments of the presently disclosed subject matter will come to the mind of those of ordinary skill in the art to which the presently disclosed subject matter pertains, and which are intended to be and are covered by both this disclosure and the appended claims.
(54) It is indeed intended that the scope of some embodiments should be determined by proper interpretation and construction of the appended claims and their legal equivalents, as understood by those of ordinary skill in the art relying upon the disclosure in this specification and the attached figures.
REFERENCES
(55) United States Food and Drug Administration (2010) White Paper: Infusion Pump Improvement Initiative; http://www.fda.gov/medicaldevices/productsandmedicalprocedures/GeneralHospitalDevicesandSupplies/InfusionPumps/ucm205424.htm#types. National Patient Safety Agency (2004) Safer practice notice; Issue 1; 20 May 2004. Mizuuchi, M. and A. Namiki (2003) The infusion rate of most disposable, non-electric infusion pumps decrease under hypobaric conditions, Can J Anesth 7 (50). Grissinger, M. (2013) Improved Safety Needed in Handling Elastomeric Reservoir Balls Used for Pain Relief, Medication Errors, Vol. 38 No. 5, May 2013. Irish Medicines Board (2008) Disposable Infusion Devices IMB Safety Notice: SN2008(06) Medical Device Safety Notice. Ganapathy, S. Amendola, A. Lichfield, R. Fowler, P. J. and Ling, E. (2000) Elastomeric pumps for ambulatory patient controlled regional analgesia, Can J Anesth, 47 (9). Thornton, P. (2015) Medication Safety, Journal of Pharmacy Practice and Research, 45, 450-458. Institute for Safe Medication Practices Canada (2015) Selection of Incorrect Medication Pump Leads to Chemotherapy Overdose, ISMP Canada Safety Bulletin, 15 (7).